Literature DB >> 17485399

The human telomere and its relationship to human disease, therapy, and tissue engineering.

Ian K Moon1, Michael B Jarstfer.   

Abstract

The chromosomes of eukaryotes end in a specialized complex of proteins and repetitive DNA called the telomere. Telomeres form a protective cap that prevents chromosome fusions, protects chromosome ends from degradation, and assists in positioning chromosomes in the nucleus. In the absence of replenishing mechanisms, telomeric DNA is lost during each cell cycle owing to incomplete replication, oxidative damage, and nucleolytic degradation. The ribonucleoprotein complex telomerase offsets this loss of telomeric DNA, but its activity is absent in most differentiated human cells. Thus, the aging process results in ever shortening lengths of telomeric DNA. Related to this is the requirement for a mechanism of telomeric DNA maintenance in tumors, leading to telomerase expression in >85% of all cancers cells. The integral roles of telomere biology in these pathophysiological states have substantially motivated its investigation. Here, the literature on the human telomere will be reviewed with an emphasis on the relationship to human health.

Entities:  

Mesh:

Year:  2007        PMID: 17485399     DOI: 10.2741/2412

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.

Authors:  Lisa Mirabello; Wen-Yi Huang; Jason Y Y Wong; Nilanjan Chatterjee; Douglas Reding; E David Crawford; Immaculata De Vivo; Richard B Hayes; Sharon A Savage
Journal:  Aging Cell       Date:  2009-06-01       Impact factor: 9.304

2.  Worldwide genetic structure in 37 genes important in telomere biology.

Authors:  L Mirabello; M Yeager; S Chowdhury; L Qi; X Deng; Z Wang; A Hutchinson; S A Savage
Journal:  Heredity (Edinb)       Date:  2011-07-06       Impact factor: 3.821

3.  The association of telomere length and genetic variation in telomere biology genes.

Authors:  Lisa Mirabello; Kai Yu; Peter Kraft; Immaculata De Vivo; David J Hunter; Jennifer Prescott; Jason Y Y Wong; Nilanjan Chatterjee; Richard B Hayes; Sharon A Savage
Journal:  Hum Mutat       Date:  2010-09       Impact factor: 4.878

4.  Recent advances of Blood telomere length (BTL) shortening: A potential biomarker for development of cancer.

Authors:  Paramita Mandal
Journal:  Pathol Oncol Res       Date:  2018-06-08       Impact factor: 3.201

5.  Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres.

Authors:  Wei Dai; Jian Wu; Danyang Wang; Jinke Wang
Journal:  Gene Ther       Date:  2020-02-07       Impact factor: 5.250

6.  ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.

Authors:  Joana Soares; Brian R Keppler; Xihong Wang; Kuo-Hsiung Lee; Michael B Jarstfer
Journal:  Bioorg Med Chem Lett       Date:  2011-10-08       Impact factor: 2.823

7.  Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.

Authors:  Eric S Kim; Yuanqing Ye; Ara A Vaporciyan; Jinliang Xing; Maosheng Huang; Jian Gu; Jack A Roth; Scott M Lippman; Xifeng Wu
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

8.  Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.

Authors:  Lisa Mirabello; Montserrat Garcia-Closas; Richard Cawthon; Jolanta Lissowska; Louise A Brinton; Beata Pepłońska; Mark E Sherman; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2009-09-27       Impact factor: 2.506

9.  The MNS16A VNTR polymorphism of the TERT gene in bladder cancer.

Authors:  Songül Budak Diler; Fikriye Polat; Günsel Bingöl
Journal:  Turk J Urol       Date:  2019-11-29

10.  Identification of telomerase RNAs from filamentous fungi reveals conservation with vertebrates and yeasts.

Authors:  Paulius V Kuprys; Shaun M Davis; Tyler M Hauer; Max Meltser; Yehuda Tzfati; Karen E Kirk
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.